MTOR and cardiac rhabdomyoma: As a specific fetal manifestation of TSC, with the pathogenesis of cardiac rhabdomyoma involving TSC1 mutations that induce aberrant activation of the mammalian target of rapamycin (mTOR) pathway, resulting in abnormal myocardial cell proliferation.